Trexquant Investment LP Crispr Therapeutics Ag Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$60.67 - $89.12 $5.01 Million - $7.36 Million	-82,598 Reduced 62.39%	49,787 $3.39 Million
Q4 2023 Feb 09, 2024	BUY	$38.62 - $72.18 $5.11 Million - $9.56 Million	132,385 New	132,385 $8.29 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $1.57 Million - $2.45 Million	36,113 New	36,113 $2.03 Million
Q2 2022 Aug 11, 2022	BUY	$43.23 - $73.83 $217,057 - $370,700	5,021 New	5,021 $305,000
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $1.09 Million - $1.76 Million	-10,855 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $1.2 Million - $2.28 Million	10,855 New	10,855 $1.32 Million
Q3 2020 Nov 06, 2020	SELL	$78.5 - $100.64 $477,908 - $612,696	-6,088 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$38.5 - $76.05 $1.58 Million - $3.13 Million	-41,167 Reduced 87.12%	6,088 $447,000
Q1 2020 May 08, 2020	SELL	$33.68 - $62.53 $223,567 - $415,074	-6,638 Reduced 12.32%	47,255 $2 Million
Q4 2019 Feb 12, 2020	BUY	$36.68 - $73.13 $1.6 Million - $3.18 Million	43,529 Added 420.0%	53,893 $3.28 Million
Q3 2019 Nov 08, 2019	BUY	$40.99 - $52.56 $18,978 - $24,335	463 Added 4.68%	10,364 $425,000
Q2 2019 Aug 09, 2019	BUY	$35.45 - $48.2 $350,990 - $477,228	9,901 New	9,901 $466,000
Q1 2019 May 13, 2019	SELL	$28.02 - $40.87 $1.53 Million - $2.23 Million	-54,558 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$22.73 - $42.34 $1.11 Million - $2.07 Million	48,925 Added 868.54%	54,558 $1.56 Million
Q3 2018 Nov 09, 2018	BUY	$44.35 - $65.71 $249,823 - $370,144	5,633 New	5,633 $250,000
Q2 2018 Aug 07, 2018	SELL	$42.62 - $73.59 $486,294 - $839,661	-11,410 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$23.52 - $58.17 $161,700 - $399,918	-6,875 Reduced 37.6%	11,410 $522,000
Q4 2017 Feb 09, 2018	BUY	$16.95 - $23.48 $309,930 - $429,331	18,285	18,285 $429,000

Others Institutions Holding CRSP

# of Institutions

488

Shares Held

59.1M

Call Options Held

1.09M

Put Options Held

1.9M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.97M
Shares

$364 Million
3.09% of portfolio
Capital International Investors Los Angeles, CA

7.93M
Shares

$322 Million
0.07% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$122 Million
0.01% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$120 Million
1.61% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$113 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.17B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account